WallStreetZen

NYSE: NVS
Novartis Ag Stock Forecast, Predictions & Price Target

Analyst price target for NVS

Based on 1 analysts offering 12 month price targets for Novartis Ag.
Min Forecast
$105.00+19.93%
Avg Forecast
$105.00+19.93%
Max Forecast
$105.00+19.93%

Should I buy or sell NVS stock?

Buy
Strong Buy
2 analysts 50%
Buy
0 analysts 0%
Hold
2 analysts 50%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

NVS stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDate
Emmanuel Papadakis
Deutsche Bank
Strong BuyInitiates Coverage OnN/AN/A2021-01-15
Anonymous
Morgan Stanley
Strong BuyUpgradesN/AN/A2020-09-01
David Toung
Argus Research
HoldDowngradesN/AN/A2021-03-10
Steve Scala
Cowen & Co.
HoldDowngrades$105.00+19.93%2021-02-01

1 of 1

Forecast return on equity

Is NVS forecast to generate an efficient return?
Company
32.62%
Industry
76.5%
Market
32,369.88%
NVS's Return on Equity is forecast to be high in 3 years (32.62%); analysts are confident in the firm's ability to efficiently generate return on equity
Forecast

Forecast return on assets

Is NVS forecast to generate an efficient return on assets?
Company
15.29%
Industry
16.91%
Market
11,660.33%
NVS is forecast to generate lower Return on Assets (15.29%) than the US Drug Manufacturers - General industry average (16.91%)
Forecast

NVS earnings per share forecast

What is NVS's earnings per share in the next 3 years based on estimates from 5 analysts?
Avg 1 year Forecast
$6.44+25.86%
Avg 2 year Forecast
$6.88+34.38%
Avg 3 year Forecast
$7.30+42.58%
NVS's earnings are forecast to grow at a rate of 12.58% per year, which is not exceptional
Forecast

NVS revenue forecast

What is NVS's revenue in the next 3 years based on estimates from 2 analysts?
Avg 1 year Forecast
$53.2B+9.2%
Avg 2 year Forecast
$55.4B+13.74%
Avg 3 year Forecast
$56.4B+15.93%
NVS's revenue is forecast to grow at a rate of 5.17% per year, which is not exceptional
Forecast

NVS earnings growth forecast

How is NVS forecast to perform vs Drug Manufacturers - General companies and vs the US market?
Company
12.58%
Industry
33.91%
Market
23.13%
NVS's earnings are forecast to grow slower (12.58% per year) than the US Drug Manufacturers - General industry average (33.91%)
Forecast
NVS's earnings are forecast to grow slower (12.58% per year) than the US market average (23.13%)
Forecast
NVS's earnings are forecast to grow faster (12.58% per year) than the risk-free savings rate (1.7%)
Forecast

NVS revenue growth forecast

How is NVS forecast to perform vs Drug Manufacturers - General companies and vs the US market?
Company
5.17%
Industry
5.95%
Market
15.05%
NVS's revenues are forecast to grow slower (5.17% per year) than the US Drug Manufacturers - General industry average (5.95%)
Forecast
NVS's revenues are forecast to grow slower (5.17% per year) than the US market average (15.05%)
Forecast

Novartis Ag Stock Forecast FAQ

Is Novartis Ag Stock a good buy in 2021, according to Wall Street analysts?

The consensus among 4 Wall Street analysts covering (NYSE: NVS) stock is to Buy NVS stock.

Out of 4 analysts, 2 (50%) are recommending NVS as a Strong Buy, 0 (0%) are recommending NVS as a Buy, 2 (50%) are recommending NVS as a Hold, 0 (0%) are recommending NVS as a Sell, and 0 (0%) are recommending NVS as a Strong Sell.

What is NVS's earnings growth forecast for 2021-2023?

(NYSE: NVS) Novartis Ag's forecast annual earnings growth rate of 12.58% is not forecast to beat the US Drug Manufacturers - General industry's average forecast earnings growth rate of 33.91%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 23.13%.

Novartis Ag's earnings in 2021 is $11,732,000,000.On average, 5 Wall Street analysts forecast NVS's earnings for 2021 to be $14,893,188,688, with the lowest NVS earnings forecast at $14,675,938,574, and the highest NVS earnings forecast at $15,138,172,860. On average, 4 Wall Street analysts forecast NVS's earnings for 2022 to be $15,900,859,432, with the lowest NVS earnings forecast at $15,507,960,289, and the highest NVS earnings forecast at $16,386,205,432.

In 2023, NVS is forecast to generate $16,871,551,432 in earnings, with the lowest earnings forecast at $16,524,875,717 and the highest earnings forecast at $17,218,227,146.

What is NVS's revenue growth forecast for 2021-2023?

(NYSE: NVS) Novartis Ag's forecast annual revenue growth rate of 5.17% is not forecast to beat the US Drug Manufacturers - General industry's average forecast revenue growth rate of 5.95%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 15.05%.

Novartis Ag's revenue in 2021 is $48,677,000,000.On average, 2 Wall Street analysts forecast NVS's revenue for 2021 to be $122,855,032,098,210, with the lowest NVS revenue forecast at $120,830,538,373,263, and the highest NVS revenue forecast at $124,879,525,823,157. On average, 2 Wall Street analysts forecast NVS's revenue for 2022 to be $127,962,385,836,443, with the lowest NVS revenue forecast at $124,456,096,105,650, and the highest NVS revenue forecast at $131,468,675,567,236.

In 2023, NVS is forecast to generate $130,419,900,640,327 in revenue, with the lowest revenue forecast at $125,137,059,655,490 and the highest revenue forecast at $135,702,741,625,164.

What is NVS's forecast return on assets (ROA) for 2021-2024?

(NYSE: NVS) forecast ROA is 15.29%, which is lower than the forecast US Drug Manufacturers - General industry average of 16.91%.

What is NVS's Price Target?

According to 1 Wall Street analysts that have issued a 1 year NVS price target, the average NVS price target is $105.00, with the highest NVS stock price forecast at $105.00 and the lowest NVS stock price forecast at $105.00.

On average, Wall Street analysts predict that Novartis Ag's share price could stay at $105.00 by Mar 10, 2022. The average Novartis Ag stock price prediction forecasts a potential downside of N/A from the current NVS share price of $87.55.

What is NVS's Earnings Per Share (EPS) forecast for 2021-2023?

(NYSE: NVS) Novartis Ag's current Earnings Per Share (EPS) is $5.12. On average, analysts forecast that NVS's EPS will be $6.44 for 2021, with the lowest EPS forecast at $6.35, and the highest EPS forecast at $6.55. On average, analysts forecast that NVS's EPS will be $6.88 for 2022, with the lowest EPS forecast at $6.71, and the highest EPS forecast at $7.09. In 2023, NVS's EPS is forecast to hit $7.30 (min: $7.15, max: $7.45).

What is NVS's forecast return on equity (ROE) for 2021-2024?

(NYSE: NVS) forecast ROE is 32.62%, which is considered strong.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.